Press Release, 13 August 2019:
“A West Yorkshire healthcare technology business has secured £650,000 funding from NPIF – Mercia Equity Finance, which is managed by Mercia and is part of the Northern Powerhouse Investment Fund.
The funding will enable Saltaire-based Advanced Digital Innovation (UK) Ltd (ADI) to boost uptake of its flagship product, MyPathway.
The product, which is already used by a number of NHS trusts, removes the need for appointment letters and calls and allows patients to negotiate care plans with clinicians.
ADI has been working with Sheffield Teaching Hospitals NHS Foundation Trust for more than two years, with North West Boroughs Healthcare NHS Foundation Trust for more than a year and has recently won a further contract with NHS North East Essex CCG.
The company has also carried out two successful clinical trials with the Hospital Clinic of Barcelona. It is now looking to sign up other trusts across the UK. The investment will allow it to build its sales and marketing team and further develop its product.
John Eaglesham, ADI chief executive, said: “At ADI, we are committed to bringing the digital revolution to the NHS and its patients.
“MyPathway provides both sides with the control and choice that we take for granted in other services. The NHS is undergoing a digital transformation and MyPathway is uniquely positioned to deliver this change in a cost-effective manner.”
Jonathan Sharp, investment manager with Mercia, added: “MyPathway revolutionises the relationship between patients and healthcare providers, saving time and money and making the patient’s healthcare journey much easier to manage. The investment will allow ADI to drive sales growth and build awareness of the product in the healthcare market.”
Freeths provided legal advice to the company while Schofield Sweeney advised Mercia and the Fund.
The Northern Powerhouse Investment Fund project is supported financially by the European Union using funding from the European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020 and the European Investment Bank.”
To learn more about MyPathway® click on our brochure or watch the video and discover the benefits from the patient, clinician and CCG’s point of view.
Pictured (L-R): Sally Abbatt, Bob Gomersall and John Eaglesham of ADI with Jonathan Sharp of Mercia